Panacea Life Sciences Holdings, Inc.
PLSH
$0.0539
$0.005912.29%
03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 117.10K | 115.90K | 79.90K | 468.60K | 998.30K |
Total Receivables | 270.90K | 264.00K | 808.80K | 772.10K | 774.80K |
Inventory | 4.06M | 4.01M | 4.69M | 4.36M | 4.10M |
Prepaid Expenses | 192.10K | 263.00K | 292.60K | 149.30K | 78.50K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 4.64M | 4.66M | 5.87M | 5.75M | 5.95M |
|
|||||
Total Current Assets | 4.64M | 4.66M | 5.87M | 5.75M | 5.95M |
Net Property, Plant & Equipment | 9.76M | 10.31M | 9.84M | 9.92M | 10.42M |
Long-term Investments | 3.01M | 3.01M | 3.01M | 2.19M | 2.19M |
Goodwill | 3.01M | 3.01M | 3.01M | 2.19M | 2.19M |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 17.41M | 17.98M | 18.73M | 17.85M | 18.56M |
|
|||||
Total Accounts Payable | 5.18M | 4.63M | 3.94M | 3.35M | 3.07M |
Total Accrued Expenses | -- | -- | -- | -- | -- |
Short-term Debt | 386.20K | 507.00K | 214.10K | 214.10K | 214.10K |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 14.83M | 14.31M | 14.02M | 13.16M | 12.61M |
Total Finance Division Other Current Liabilities | -- | -- | 361.70K | 330.50K | -- |
Total Other Current Liabilities | -- | -- | 361.70K | 330.50K | -- |
Total Current Liabilities | 20.39M | 19.45M | 18.54M | 17.05M | 15.89M |
|
|||||
Total Current Liabilities | 20.39M | 19.45M | 18.54M | 17.05M | 15.89M |
Long-Term Debt | 3.57M | 3.57M | 3.57M | 3.57M | 3.57M |
Short-term Debt | 386.20K | 507.00K | 214.10K | 214.10K | 214.10K |
Capital Leases | 3.07M | 3.25M | 2.71M | 2.80M | 2.89M |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 27.04M | 26.27M | 24.82M | 23.42M | 22.36M |
|
|||||
Common Stock & APIC | 25.75M | 25.63M | 25.63M | 24.00M | 23.90M |
Retained Earnings | -35.37M | -33.92M | -31.71M | -29.56M | -27.70M |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -9.62M | -8.29M | -6.08M | -5.57M | -3.80M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | 1.20K | 1.20K | 1.60K | 900.00 | 900.00 |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | 1.20K | 1.20K | 1.60K | 900.00 | 900.00 |
|
|||||
Total Common Equity | -9.62M | -8.29M | -6.08M | -5.57M | -3.80M |
Total Preferred Equity | 1.20K | 1.20K | 1.60K | 900.00 | 900.00 |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -9.62M | -8.29M | -6.08M | -5.57M | -3.80M |
|